Mobius Therapeutics, founded as an early-stage venture, is dedicated to providing innovative solutions in the field of ophthalmic surgery. The company's core mission is to identify and address challenging needs in ophthalmic perioperative pharmaceuticals, continually improving patient outcomes and surgical efficiency. Mobius Therapeutics offers a range of specialized products designed to support ophthalmic surgeries, focusing on enhancing the perioperative experience for both patients and healthcare providers.
Notable figures affiliated with Mobius Therapeutics include a team of experienced professionals in the fields of ophthalmology and pharmaceuticals. The company has garnered attention from investors interested in advancing medical technology and improving surgical outcomes. Key achievements include the successful development and deployment of their product lineup, which has positively impacted the ophthalmic surgery market by providing reliable and effective perioperative solutions. Mobius Therapeutics continues to make significant strides in the industry, contributing to better patient care and surgical practices.
Mobius Therapeutics' most recent funding round was for $5M (USD) in October 2013.
As of Oct 10, 2013, Mobius Therapeutics has disclosed funding of $8.5M (USD).

Visiox
visioxpharma.com

Perfuse Therapeutics

Aurion Biotech
aurionbiotech.com

Pathfinder Therapeutics
pathnav.com

MingSight Pharmaceuticals
mingsight.com

EyeCyte
eyecyte.com

Radiance Therapeutics

Ocular Therapeutix
ocutx.com

Surgicare of Mobile

MBX Biosciences
mbxbio.com

Pykus Therapeutics

SURGE Therapeutics
surgetx.com

CarthroniX
carthronix.com

MediPrint Ophthalmics
mediprintlens.com

Phanes Therapeutics
phanesthera.com

Nimbus Therapeutics
nimbustx.com

Orbus Therapeutics

Mojave Pharma

MOMA Therapeutics
momatx.com

Luminopia
luminopia.com